LENZ Award Disclosure
Chevallard Daniel R. · SEC Form 4 · Filed Nov 3, 2026
Award
Calculated transaction value
$0
Chevallard Daniel R. Chief Financial Officer
LENZ
LENZ Therapeutics
LENZ
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
LENZ daily price context
Close on/before transaction
$3.05
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 652,063 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001706176-26-000007
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lenz Therapeutics, Inc. LENZ Current | Award | Oct 30, 2026 | $0 |